SS

Santosh C. Sinha

AB AbbVie: 42 patents #32 of 1,308Top 3%
Overall (All Time): #73,693 of 4,157,543Top 2%
42
Patents All Time

Issued Patents All Time

Showing 25 most recent of 42 patents

Patent #TitleCo-InventorsDate
9849113 Methods of treating α adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2017-12-26
9623006 Methods of treating α adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2017-04-18
9522150 Alpha adrenergic receptor modulators Ken Chow, Liming Wang, Wenkui K. Fang, Evelyn G. Corpuz, Daniel W. Gil +2 more 2016-12-20
9402913 Cyclosporine A steroid conjugates Ken Chow, Liming Wang, Michael E. Garst, Mayssa Attar, Brandon Dale Swift 2016-08-02
9402912 Antibiotic conjugates directly linked with steroid drugs Ken Chow, Liming Wang, Michael E. Garst, Mayssa Attar, Brandon Dale Swift 2016-08-02
9199989 N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors Liming Wang, Mohammed I. Dibas, Michael E. Garst, Ken Chow 2015-12-01
9079864 Modulators of S1P receptors Smita S. Bhat, Ken Chow, Michael E. Garst, Wha-Bin Im 2015-07-14
9040532 Alpha adrenergic receptor modulators Ken Chow, Liming Wang, Wenkui K. Fang, Evelyn G. Corpuz, Daniel W. Gil +2 more 2015-05-26
9034910 Methods of treating alpha adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2015-05-19
9034896 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst 2015-05-19
8993553 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wha-Bin Im, Wenkui K. Fang 2015-03-31
8815923 Therapeutic compounds Smita S. Bhat, Todd M. Heidelbaugh, Daniel W. Gil, Ken Chow, Michael E. Garst 2014-08-26
8815861 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst 2014-08-26
8809379 Selective subtype alpha 2 adrenergic agents and methods for use thereof Todd M. Heidelbaugh, Ken Chow, Phong X. Nguyen, Ling Li, Wenkui K. Fang +2 more 2014-08-19
8741921 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst 2014-06-03
8735399 Selective subtype alpha 2 adrenergic agents and methods for use thereof Todd M. Heidelbaugh, Ken Chow, Phong X. Nguyen, Wenkui K. Fang, Ling Li +2 more 2014-05-27
8735438 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors Todd M. Heidelbaugh, Smita S. Bhat, Ken Chow, Michael E. Garst 2014-05-27
8541397 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wenkui K. Fang, Wha-Bin Im 2013-09-24
8530462 Indole modulators of S1P receptors Smita S. Bhat, Ken Chow, Michael E. Garst, Wha-Bin Im 2013-09-10
8513419 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst 2013-08-20
8492561 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wenkui K. Fang, Wha-Bin Im 2013-07-23
8486969 Therapeutic compounds Smita S. Bhat, Todd M. Heidelbaugh, Daniel W. Gil, Ken Chow, Michael E. Garst 2013-07-16
8431702 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds Smita S. Bhat, Ken Chow, Richard L. Beard, John E. Donello, Michael E. Garst 2013-04-30
8426454 Therapeutic compounds Smita S. Bhat, Todd M. Heidelbaugh, Daniel W. Gil, Ken Chow, Michael E. Garst 2013-04-23
8404663 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators Smita S. Bhat, Evelyn G. Corpuz, Ken Chow, Wenkui K. Fang, Wha-Bin Im 2013-03-26